Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus

Movement Disorders

Volumn 21, Issue 5, 2006, Pages 624-631

  Østergaard, Karen ^a   Sunde, Niels Aa ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Deep brain stimulation; Disease evolution; Parkinson's disease; Subthalamic nucleus

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; DYSKINESIA; FEMALE; GAIT DISORDER; GENERAL CONDITION DETERIORATION; HUMAN; MALE; MORTALITY; MOTOR PERFORMANCE; NEUROSURGERY; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SCORING SYSTEM; SPEECH DISORDER; SUBTHALAMIC NUCLEUS; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; BODY WEIGHT; DEEP BRAIN STIMULATION; DISEASE PROGRESSION; DYSKINESIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR ACTIVITY; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 33646925626     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20776     Document Type: Article

References (24)

1. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-1111.
2. The Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
3. Ostergaard K, Sunde NAa, Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 2002;17:693-700.
4. Welter ML, Houeto JL, du Montcel T, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-583.
5. Houeto JL, Mallet L, Pillon B, et al. Behavioral disorders, Parkinson's disease, and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002;72:701-707.
6. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002; 59:932-934.
7. Martinez-Martin P, Valldeoriola F, Tolosa E, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord 2002;17:372-377.
8. Just H, Ostergaard K. Health-Related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord 2002;17:539-545.
9. Binder DK, Rau G, Starr PA. Hemorrhagic complications of microelectrode-guided deep brain stimulation. Stereotact Funct Neurosurg 2003;80:28-31.
10. Umemura A, Jaggi JL, Hurtig HI, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg 2003;98:779-784.
11. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934.
12. Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999;46:217-223.
13. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123: 2091-2108.
14. Rodriguez-Oroz MC, Zamarbide I, Guridi J, Palmero MR, Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004;75:1382-1385.
15. Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJG. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 2003;60:78-81.
16. Koop M, Fujikami G, McGuire K, Heit G, Bronte-Stewart H. Certain aspects of motor control do not return to baseline after prolonged withdrawal of chronic bilateral subthalamic nucleus deep brain stimulation (B-STN DBS) in Parkinson's disease (PD). Neurology 2004;62(Suppl. 5):A107.
17. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and education level. JAMA 1993;269:2386-2391.
18. Clarke CE. A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs? Mov Disord 2004; 19:491-498.
19. Carvalho GA, Nikkhah G. Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp Neurol 2001;171:405-417.
20. Maesawa S, Kaneoke Y, Kajita Y, et al. Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. J Neurosurg 2004;100:679-687.
21. Rodriguez MC, Obeso JA, Olanow CW. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 1998;44(3 Suppl 1):S175-S188.
22. Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000;54:1596-1603.
23. Aarsland D, Andersen Y, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson's disease. Arch Neurol 2003;60:387-392.
24. Hariz MI. Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact Funct Neurosurg 2002;78: 146-157.